- Nachrichtendetail
-
25.03.2024 12:13:46 - dpa-AFX: *REGENERON: FDA ISSUES CRLS FOR ODRONEXTAMAB BLA IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA AND R/R DIFFUSE LARGE B-CELL LYMPHOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 980,000 | 20.06.24 12:12:01 | +16,200 | +1,68% | 975,000 | 977,000 | 966,200 | 963,800 |
